Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net Sales	$ 1,783.8	$ 1,975.5
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 487.1	$ 553.4
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 147.6	$ 143.4
Research and development	98.4	101.7
Selling, general and administrative	828.9	796.4
Goodwill impairment	612.0
Restructuring and other cost reduction initiatives	45.0	4.7
Quality remediation	16.4	19.7
Acquisition, integration and related	4.4	6.0
Operating expenses	2,239.8	1,625.3
Operating (Loss) Profit	(456.0)	350.2
Other income (expense), net	3.0	(0.5)
Interest expense, net	(50.9)	(58.0)
(Loss) earnings before income taxes	(503.9)	291.7
Provision for income taxes	5.2	45.5
Net (Loss) Earnings	(509.1)	246.2
Less: Net (loss) earnings attributable to noncontrolling interest	(0.6)	0.1
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	$ (508.5)	$ 246.1
(Loss) Earnings Per Common Share
Basic	$ (2.46)	$ 1.20
Diluted	$ (2.46)	$ 1.20
Weighted Average Common Shares Outstanding
Basic	206.5	204.4
Diluted	206.5	205.8